|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Jieping Zhu (ICSN, CNRS, Gif-sur-Yvette Cedex, France) , Hugues Bienaymé (Chrysalon, Villeurbanne Cedex, France)Publisher: Wiley-VCH Verlag GmbH Imprint: Blackwell Verlag GmbH Dimensions: Width: 17.80cm , Height: 2.80cm , Length: 24.60cm Weight: 1.034kg ISBN: 9783527308064ISBN 10: 3527308067 Pages: 484 Publication Date: 26 January 2005 Audience: Professional and scholarly , College/higher education , Professional & Vocational , Undergraduate Format: Hardback Publisher's Status: Out of Print Availability: In Print ![]() Limited stock is available. It will be ordered for you and shipped pending supplier's limited stock. Table of ContentsReviews...it will be useful to the specialists in the field. Naturally, librarians may also like to acquire this book. Angewandte Chemie Das Buch hat mich sehr positiv uberrascht. Gerade die Vielfalt an beschriebenen Methoden und indirekt an moeglichen Zielstrukturen machen >Multicomponent Reactions< zu einem unverzichtbaren Werkzeug fur Anwender, welche in der Parallelchemie arbeiten. www.organische-chemie.ch Fortgeschrittene, die sich fur MCR interessieren oder auf diesem Gebiet arbeiten, werden in diesem Buch eine Quelle der Inspiration finden. Nachrichten aus der Chemie ....ist diese erste Monographie uber Multikomponentenreaktionen fur Spezialisten auf dem Gebiet recht nutzlich, und selbstverstandlich sollten auch Bibliotheken eine Anschaffung ins Auge fassen. Angewandte Chemie ...it will be useful to the specialists in the field. Naturally, librarians may also like to acquire this book. Angewandte Chemie Das Buch hat mich sehr positiv A1/4berrascht. Gerade die Vielfalt an beschriebenen Methoden und indirekt an mAglichen Zielstrukturen machen >Multicomponent Reactions< zu einem unverzichtbaren Werkzeug fA1/4r Anwender, welche in der Parallelchemie arbeiten. www.organische-chemie.ch Fortgeschrittene, die sich fA1/4r MCR interessieren oder auf diesem Gebiet arbeiten, werden in diesem Buch eine Quelle der Inspiration finden. Nachrichten aus der Chemie ....ist diese erste Monographie A1/4ber Multikomponentenreaktionen fA1/4r Spezialisten auf dem Gebiet recht nA1/4tzlich, und selbstverstAndlich sollten auch Bibliotheken eine Anschaffung ins Auge fassen. Angewandte Chemie an indispensable reference work for all synthetic chemists, more specifically to those interested in diversity-oriented and parallel synthesis. ( Synthesis, July 2006) ...an indispensable reference work for all synthetic chemists, more specifically to those interested in diversity-oriented and parallel synthesis. (Synthesis, July 2006) Author Information"Jieping Zhu received his BSc from Hanzhou Normal University in 1984 and his MSc from Lanzhou University in 1987 under Professor Y. -L. Li. In 1991, he obtained his PhD from the Université Paris XI under Professor H. -P. Husson. After 18 months post-doctoral research with Professor Sir D. H. R. Barton at Texas A & M University in USA, he joined the Institut de Chimie des Substances Naturelles (CNRS) in December 1992, where he is currently Director of Research. His main research interests center on the development of novel synthetic methods, their application in the synthesis of bioactive natural products, and the design of novel multicomponent reactions. Dr. Zhu has published over 110 research papers. Hugues Bienaymé gained his PhD in organic chemistry at the university of Paris under Professor A. Lubineau, than took up a post-doctoral position at the University of Geneva under the supervision of Professor W. Oppolzer. He joined Rhône-Poulenc (Aventis) in 1991 where he held various research positions in process and discovery chemistry. From 1995 to 2000 he was head of the combinatorial and discovery chemistry group for the company's central research department, developing multi-component condensations as a general tool to accelerate drug discovery. In 1996 the company awarded him the title ""associate professor"". In 2001, Dr. Bienaymé founded Chrysalon, a start-up in the field of combinatorial chemistry. After the company's merger in 2003, he became managing director and CSO of Urogene, a biotech company dedicated to discovering new drugs in urology. Hugues Bienaymé is the author or co-author of more than 40 publications and patents." Tab Content 6Author Website:Countries AvailableAll regions |